Workflow
HPV男女共防
icon
Search documents
首届HPV科普创意大赛落幕,助力提升男女共防意识
Bei Ke Cai Jing· 2025-06-24 02:23
中国医师协会健康传播工作委员会常务副主委兼秘书长施琳玲表示:"HPV感染是威胁人类健康的重要 公共卫生问题之一。此次大赛中,年轻一代用他们活跃的思维和创意表达打破过往传统科普'单向输 出'的边界,让HPV相关知识可以做到'破圈'传播,激发公众从'被动接受'到'主动参与'的转变,并建立 科学、正确的HPV疾病认知,从而积极采取健康行动。" 校对 翟永军 新京报讯(记者张秀兰)6月21日,由清华大学新闻与传播学院全球发展与健康传播研究中心策划发起 的首届"无限可能杯"HPV(人乳头瘤病毒)科普创意大赛在清华大学落幕。大赛由四位导师带队指导参 赛学生们共创HPV科普作品,呼吁社会各界加强校园内HPV男女共防的健康意识,共筑校园健康防线。 HPV的感染较为普遍,几乎所有的宫颈癌都与HPV感染有关。事实上,HPV感染对于男性也可能造成影 响,是所有人都可能遇到的健康挑战。有研究显示,在HPV疫苗上市前,至少有1位异性伴侣的人,超 过80%的男人和女人一生中会感染至少一种HPV型别。HPV感染具有感染概率高、感染途径多等特点。 大赛由北京协和医院妇科内分泌与生殖中心副主任陈蓉教授、清华大学万科公共卫生与健康学院长聘副 教 ...
推动同防共治 男性九价HPV疫苗首批开打
Mei Ri Shang Bao· 2025-05-12 22:22
Core Viewpoint - The recent approval of the nine-valent HPV vaccine for males aged 16-26 marks a significant advancement in the prevention of HPV-related cancers and diseases in China, promoting a new phase of gender-inclusive HPV prevention efforts [1] Group 1: HPV Vaccine Approval and Public Health Impact - The nine-valent HPV vaccine has received approval from the National Medical Products Administration for use in males aged 16-26, indicating a shift towards gender-inclusive HPV prevention strategies in China [1] - An academic conference themed "Gender-inclusive Prevention: Accelerating the Elimination of Cervical Cancer" was held, where experts discussed the role of the HPV gender-inclusive prevention plan in enhancing public health [1] Group 2: Male HPV Infection Rates and Awareness - HPV infection is a significant public health issue, with studies indicating that approximately 90% of men will be infected with HPV at least once in their lifetime, and the infection rate in males is higher than in females [2] - Continuous infection with high-risk HPV types can lead to increased risks of various cancers in men, including anal, penile, and oropharyngeal cancers, with 88% of anal cancers attributed to persistent HPV infection [2] Group 3: Vaccine Efficacy and Recommendations - Research confirms that the HPV vaccine provides long-lasting protection and has a good safety profile, with no breakthrough cases of vaccine-type genital warts, anal cancer, or serious adverse events reported over a 10-year follow-up [3] - Vaccination is highlighted as the best method for preventing cervical cancer and other HPV-related cancers, reducing the likelihood of infection and transmission among males [3] - There has been a notable increase in inquiries and appointments for the nine-valent HPV vaccine among eligible males since its approval, indicating growing public interest and awareness [3]